Khalil, M; Harrasser, M; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, F; Reindl, M; Berger, T.
The ability of anti MOG antibodies to fix the terminal complement complex differs among multiple sclerosis patients with different disease courses
MULT SCLER. 2004; 10(7032): S104-S104.
Web of Science